Carl Philpott is an expert in Otolaryngology at James Paget University Hospitals NHS Foundation Trust (United Kingdom). As of October 2026, ScienceLeadR ranks Carl Philpott in the top 1% of experts worldwide for Nose Diseases and Rhinitis, and in the top 1% of experts in the United Kingdom for Taste Disorders. Carl Philpott has authored 261 publications, the most recent in 2026, and is an investigator in 4 clinical trials, 1 of them ongoing. SLR score: 831 (community average: 125). How the SLR is computed.

LeadR Profile

831 ScienceLeadR Reputation 831
Network Map

Otolaryngology

Subspecialties: Neurology - Psychology - Immunology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2004 - 2026

Source: PubMed

James Paget University Hospital

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 261

Citations

Citations: 13 615 1st author: 60 Last author: 72 Unique author: 8


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Clinical Studies 4

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 2
Phase 3 2

By status:

Completed 3
Recruiting 1

By type:

Interventional 3
Observational 1

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 1
multicentric5to9 0
multicentricup10 2

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST NP)
NCT06338995 — safety, adrenal cortex hormones, polyps, therapeutics, nasal polyps, rhinosinusitis
Phase 3Recruiting2024

LeadR Networks

Main global connection map